欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6861/001
药品名称Bortezomib beta 3,5 mg Pulver zur Herstellung einer Injektionslösung
活性成分
    • BORTEZOMIB 3.5 mg
剂型Powder for solution for injection
上市许可持有人Betapharm Arzneimittel GmbH Kobelweg 95 86156 Augsburg Germany
参考成员国 - 产品名称Germany (DE)
Bortezomib beta 3,5 mg Pulver zur Herstellung einer Injektionslösung
互认成员国 - 产品名称
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Bortezomib Reddy
    • Hungary (HU)
      Bortezomib Reddy 3.5 mg por oldatos injekcióhoz
    • Czechia (CZ)
      Bortezomib Reddy
    • Denmark (DK)
    • Slovakia (SK)
    • Netherlands (NL)
    • Ireland (IE)
    • Austria (AT)
许可日期2022/01/19
最近更新日期2024/07/16
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase